Catani L.; Cavo M.; Palandri F., The power of extracellular vesicles in myeloproliferative neoplasms: “Crafting” a microenvironment that matters, «CELLS», 2021, 10, Article number: 2316, pp. 2316 - 2331 [articolo]Open Access
Bruno S.; Mancini M.; De Santis S.; Monaldi C.; Cavo M.; Soverini S., The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, Article number: 6857, pp. 1 - 18 [articolo]Open Access
Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Cavo M.; Zinzani P.L., Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients, «ANNALS OF HEMATOLOGY», 2021, 100, pp. 2261 - 2268 [articolo]Open Access
Terpos E.; Zamagni E.; Lentzsch S.; Drake M.T.; Garcia-Sanz R.; Abildgaard N.; Ntanasis-Stathopoulos I.; Schjesvold F.; de la Rubia J.; Kyriakou C.; Hillengass J.; Zweegman S.; Cavo M.; Moreau P.; San-Miguel J.; Dimopoulos M.A.; Munshi N.; Durie B.G.M.; Raje N., Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group, «THE LANCET ONCOLOGY», 2021, 22, pp. e119 - e130 [articolo]
Moreau P.; Kumar S.K.; San Miguel J.; Davies F.; Zamagni E.; Bahlis N.; Ludwig H.; Mikhael J.; Terpos E.; Schjesvold F.; Martin T.; Yong K.; Durie B.G.M.; Facon T.; Jurczyszyn A.; Sidana S.; Raje N.; van de Donk N.; Lonial S.; Cavo M.; Kristinsson S.Y.; Lentzsch S.; Hajek R.; Anderson K.C.; Joao C.; Einsele H.; Sonneveld P.; Engelhardt M.; Fonseca R.; Vangsted A.; Weisel K.; Baz R.; Hungria V.; Berdeja J.G.; Leal da Costa F.; Maiolino A.; Waage A.; Vesole D.H.; Ocio E.M.; Quach H.; Driessen C.; Blade J.; Leleu X.; Riva E.; Bergsagel P.L.; Hou J.; Chng W.J.; Mellqvist U.-H.; Dytfeld D.; Harousseau J.-L.; Goldschmidt H.; Laubach J.; Munshi N.C.; Gay F.; Beksac M.; Costa L.J.; Kaiser M.; Hari P.; Boccadoro M.; Usmani S.Z.; Zweegman S.; Holstein S.; Sezer O.; Harrison S.; Nahi H.; Cook G.; Mateos M.-V.; Rajkumar S.V.; Dimopoulos M.A.; Richardson P.G., Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group, «THE LANCET ONCOLOGY», 2021, 22, pp. e105 - e118 [articolo]
Musto P.; Engelhardt M.; Caers J.; Bolli N.; Kaiser M.; van de Donk N.; Terpos E.; Broijl A.; de Larrea C.F.; Gay F.; Goldschmidt H.; Hajek R.; Vangsted A.J.; Zamagni E.; Zweegman S.; Cavo M.; Dimopoulos M.; Einsele H.; Ludwig H.; Barosi G.; Boccadoro M.; Mateos M.-V.; Sonneveld P.; Miguel J.S., 2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde, «HAEMATOLOGICA», 2021, 106, pp. 2799 - 2812 [articolo]Open Access
Dimopoulos, Meletios A; Cavo, Michele; Mateos, Maria-Victoria; Facon, Thierry; Heeg, Bart; van Beekhuizen, Sophie; Gebregergish, Samron B; Nair, Sandhya; Pisini, Marta; Lam, Annette; Slavcev, Mary, A matching-adjusted indirect treatment comparison (MAIC) of daratumumab-bortezomib-melphalan-prednisone (D-VMP) versus lenalidomide-dexamethasone continuous (Rd continuous), lenalidomide-dexamethasone 18 months (Rd 18), and melphalan-prednisone-thalidomide (MPT), «LEUKEMIA & LYMPHOMA», 2020, 61, pp. 714 - 720 [articolo]
Mattia D'Agostino, Juan-José Lahuerta, Ruth Wester, Anders Waage, Uta Bertsch, Elena Zamagni, Maria-Victoria Mateos, Alessandra Larocca, Daniele Dall'Olio, Niels W.C.J. Van De Donk, David Cairns, Serena Rocchi, Hans Salwender, Joan Blade Creixenti, Bronno van der Holt, Castellani Gastone, Giovannino Ciccone, Andrea Capra, Jan Dürig, Sara Bringhen, Sonja Zweegman, Michele Cavo, Hartmut Goldschmidt, Gordon Cook, Jesus Maria Hernández-Rivas, Jesus F. San-Miguel, Mario Boccadoro and Pieter Sonneveld, A new risk stratification model (R2-ISS) in Newly Diagnosed Multiple Myeloma: Analysis of Mature Data from 7077 patients collected by European Myeloma Network Within HARMONY Big Data Platform, in: 62nd ASH Annual Meeting & Exposition, 2020(atti di: 62nd ASH Annual Meeting & Exposition, All-virtual event, December 5-8,2020) [atti di convegno-poster]
Mattia D'agostino, Juan José Lahuerta, Anders Waage, Uta Bertsch, Elena Zamagni, Maria-Victoria Mateos, Alessandra Larocca, Daniele Dall'Olio, Niels WCJ van de Donk, Hans Salwender, Joan Bladé, Bronno van der Holt, Gastone Castellani, Giovannino Ciccone, Jan Dürig, Sara Bringhen, Sonja Zweegman, Michele Cavo, Hartmut Goldschmidt, Jesús María Hernandez Rivas, Jesus San Miguel, Mario Boccadoro, Pieter Sonneveld, A NEW RISK STRATIFICATION STRATEGY IN NEWLY DIAGNOSED MULTIPLE MYELOMA: AN ANALYSIS ON MATURE DATA FROM EUROPEAN CLINICAL TRIALS WITHIN THE HARMONY BIG DATA PLATFORM, in: Abstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2020, «HEMASPHERE», 2020, 4, pp. 421 - 422 (atti di: 25th Congress of the European Hematology Association - 25th EHA Congress, Virtual edition, June 11-22, 2020) [atti di convegno-abstract]Open Access
Ocadlikova D.; Iannarone C.; Redavid A.R.; Cavo M.; Curti A., A screening of antineoplastic drugs for acute myeloid leukemia reveals contrasting immunogenic effects of etoposide and fludarabine, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2020, 21, Article number: 6802, pp. 1 - 20 [articolo]Open Access
Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P., Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study, «THE LANCET. HAEMATOLOGY», 2020, 7, pp. e456 - e468 [articolo]
Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L., Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients, «HEMATOLOGICAL ONCOLOGY», 2020, 38, pp. 487 - 492 [articolo]
Mateos M.-V.; Fink L.; Koneswaran N.; Intorcia M.; Giannopoulou C.; Niepel D.; Cavo M., Bone complications in patients with multiple myeloma in five European countries: A retrospective patient chart review, «BMC CANCER», 2020, 20, Article number: 170, pp. 1 - 13 [articolo]Open Access
Forte D.; Garcia-Fernandez M.; Sanchez-Aguilera A.; Stavropoulou V.; Fielding C.; Martin-Perez D.; Lopez J.A.; Costa A.S.H.; Tronci L.; Nikitopoulou E.; Barber M.; Gallipoli P.; Marando L.; Fernandez de Castillejo C.L.; Tzankov A.; Dietmann S.; Cavo M.; Catani L.; Curti A.; Vazquez J.; Frezza C.; Huntly B.J.; Schwaller J.; Mendez-Ferrer S., Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy, «CELL METABOLISM», 2020, 32, pp. 829 - 843 [articolo]Open Access
Tacchetti P.; Pantani L.; Patriarca F.; Petrucci M.T.; Zamagni E.; Dozza L.; Galli M.; Di Raimondo F.; Crippa C.; Boccadoro M.; Barbato S.; Tosi P.; Narni F.; Montefusco V.; Testoni N.; Spadano A.; Terragna C.; Pescosta N.; Marzocchi G.; Cellini C.; Galieni P.; Ronconi S.; Gobbi M.; Catalano L.; Lazzaro A.; De Sabbata G.; Cangialosi C.; Ciambelli F.; Musto P.; Elice F.; Cavo M.; Fanin R.; Foa' R.; Rambaldi A.; Rossi G.; Leoni P.; Corradini P.; Torelli G.; Fioritoni G.; Cortelazzo S.; Lambertenghi Deliliers G.; La Nasa G.; Zaccaria A.; De Fabritiis P.; Cascavilla N.; Bosi A.; Semenzato G.; Gugliotta L.; Gherlinzoni F.; Angelucci E.; Martelli M.F.; Petti M.C.; Leone G.; Carella A.M.; Ciceri F.; Santoro A.; Ferrara F.; Nobile F.; D'Arco A.M.; Levis A.; Guardigni L.; Gallamini A.; Fattori P.P.; Morandi S.; Amadori D.; Rotoli B.; Mirto S.; Paladini G.; Mozzana R.; Pinotti G.; Rodeghiero F.; Cantore N.; Pavone V.; Pogliani E.M.; Liberati A.M.; Majolino I.; Amadori S.; Lauria F.; Aglietta M., Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study, «THE LANCET. HAEMATOLOGY», 2020, 7, pp. 861 - 873 [articolo]
